PET/CT Improves Assessment of Oesophageal Malignancy
By MedImaging International staff writers Posted on 03 Feb 2015 |
Esophageal carcinoma is the eighth most common cancer globally. It occurs in the inside lining of the esophagus, and is diagnosed by biopsy using Endoscopic Ultrasound (EUS). Treatment includes surgery, chemotherapy, radiotherapy, or palliative care. Radiotherapy is often used for both curative and palliative treatment. The outcomes of treatment are often poor because of late diagnosis, and can result in a 5-year survival rate of only 13%‒18%.
Now a new study has shown that Positron Emission Tomography/Computed Tomography (PET/CT) could be used for planning radiotherapy, surgical resection, and other treatments. The researchers assessed 53 patients who had been treated with PET/CT, EUS, Esophago-gastroduodenoscopy (OGD), and surgical resection for esophageal cancer. Tumor length was assessed retrospectively. For EUS and OGD direct measurements were made.
Results of the study showed that estimating the histopathological length of the tumor using PET/CT was the most accurate method, when compared to direct measurements by EUS. Measurements using OGD were the least accurate method.
The research team was led by Dr. K. Rollins of the Esophago-Gastric Surgery department at Nottingham University Hospitals (Nottingham, United Kingdom). The results of the study will be published in the February 2015 issue of European Journal of Radiology.
Related Links:
Nottingham University Hospitals
Now a new study has shown that Positron Emission Tomography/Computed Tomography (PET/CT) could be used for planning radiotherapy, surgical resection, and other treatments. The researchers assessed 53 patients who had been treated with PET/CT, EUS, Esophago-gastroduodenoscopy (OGD), and surgical resection for esophageal cancer. Tumor length was assessed retrospectively. For EUS and OGD direct measurements were made.
Results of the study showed that estimating the histopathological length of the tumor using PET/CT was the most accurate method, when compared to direct measurements by EUS. Measurements using OGD were the least accurate method.
The research team was led by Dr. K. Rollins of the Esophago-Gastric Surgery department at Nottingham University Hospitals (Nottingham, United Kingdom). The results of the study will be published in the February 2015 issue of European Journal of Radiology.
Related Links:
Nottingham University Hospitals
Latest Nuclear Medicine News
- New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment
- Low-Dose Radiation Therapy Demonstrates Potential for Treatment of Heart Failure